Robert Reis
Concepts (482)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Caenorhabditis elegans | 34 | 2024 | 139 | 3.960 |
Why?
| | Alzheimer Disease | 11 | 2025 | 332 | 2.370 |
Why?
| | Longevity | 21 | 2019 | 85 | 2.070 |
Why?
| | Aging | 22 | 2025 | 701 | 1.690 |
Why?
| | Caenorhabditis elegans Proteins | 12 | 2019 | 58 | 1.510 |
Why?
| | Neurodegenerative Diseases | 5 | 2025 | 80 | 1.310 |
Why?
| | Animals | 64 | 2025 | 13505 | 0.990 |
Why?
| | Mutation | 19 | 2023 | 1347 | 0.950 |
Why?
| | Phosphatidylinositol 3-Kinases | 6 | 2016 | 151 | 0.880 |
Why?
| | Chromosome Mapping | 12 | 2006 | 154 | 0.730 |
Why?
| | Recombination, Genetic | 14 | 2011 | 109 | 0.720 |
Why?
| | Hippocampus | 3 | 2025 | 201 | 0.720 |
Why?
| | Gene Regulatory Networks | 3 | 2019 | 111 | 0.710 |
Why?
| | Amyotrophic Lateral Sclerosis | 2 | 2023 | 33 | 0.700 |
Why?
| | DNA | 18 | 2021 | 549 | 0.670 |
Why?
| | Quantitative Trait Loci | 6 | 2006 | 50 | 0.650 |
Why?
| | DNA, Mitochondrial | 6 | 2017 | 114 | 0.640 |
Why?
| | Phosphatidylinositol Phosphates | 3 | 2018 | 17 | 0.600 |
Why?
| | Telomerase | 5 | 2017 | 26 | 0.590 |
Why?
| | Brain | 4 | 2023 | 1323 | 0.580 |
Why?
| | Amyloid beta-Peptides | 4 | 2021 | 66 | 0.550 |
Why?
| | Endoplasmic Reticulum Stress | 2 | 2025 | 50 | 0.530 |
Why?
| | Peptide Fragments | 4 | 2021 | 203 | 0.520 |
Why?
| | Proteins | 4 | 2018 | 348 | 0.480 |
Why?
| | Rad51 Recombinase | 4 | 2015 | 25 | 0.480 |
Why?
| | Genomic Instability | 2 | 2020 | 89 | 0.470 |
Why?
| | Humans | 71 | 2025 | 52483 | 0.470 |
Why?
| | 14-3-3 Proteins | 2 | 2022 | 18 | 0.470 |
Why?
| | Oxidative Stress | 6 | 2012 | 807 | 0.440 |
Why?
| | Aspirin | 2 | 2017 | 115 | 0.430 |
Why?
| | DNA Replication | 7 | 2017 | 160 | 0.430 |
Why?
| | Disease Models, Animal | 8 | 2025 | 1478 | 0.420 |
Why?
| | Mice | 18 | 2025 | 5949 | 0.420 |
Why?
| | Multiple Myeloma | 6 | 2020 | 3049 | 0.420 |
Why?
| | Creutzfeldt-Jakob Syndrome | 1 | 2022 | 6 | 0.410 |
Why?
| | Cardiovascular Diseases | 2 | 2025 | 490 | 0.400 |
Why?
| | Profilins | 2 | 2023 | 14 | 0.400 |
Why?
| | Apolipoprotein E4 | 2 | 2024 | 22 | 0.390 |
Why?
| | Lysosomes | 3 | 2024 | 76 | 0.390 |
Why?
| | Peptide Nucleic Acids | 3 | 2015 | 18 | 0.380 |
Why?
| | Benzylamines | 1 | 2021 | 14 | 0.370 |
Why?
| | Huntington Disease | 1 | 2021 | 24 | 0.370 |
Why?
| | Cholinesterase Inhibitors | 1 | 2021 | 25 | 0.370 |
Why?
| | Peptide Chain Elongation, Translational | 1 | 2021 | 5 | 0.360 |
Why?
| | Glutathione Transferase | 3 | 2006 | 174 | 0.360 |
Why?
| | Alkaloids | 1 | 2021 | 35 | 0.360 |
Why?
| | Mitochondria | 1 | 2025 | 430 | 0.360 |
Why?
| | Indoles | 2 | 2020 | 278 | 0.350 |
Why?
| | Thiadiazoles | 1 | 2020 | 18 | 0.350 |
Why?
| | Oxyquinoline | 1 | 2020 | 8 | 0.350 |
Why?
| | RNA | 2 | 2021 | 168 | 0.350 |
Why?
| | Autophagy | 2 | 2024 | 193 | 0.340 |
Why?
| | Chelating Agents | 1 | 2020 | 31 | 0.340 |
Why?
| | Neuroprotective Agents | 1 | 2021 | 101 | 0.340 |
Why?
| | Hematologic Neoplasms | 1 | 2022 | 106 | 0.340 |
Why?
| | Stress, Physiological | 4 | 2015 | 183 | 0.340 |
Why?
| | Drug Design | 1 | 2020 | 120 | 0.330 |
Why?
| | RNA Interference | 7 | 2016 | 181 | 0.320 |
Why?
| | Myocardial Infarction | 1 | 2023 | 412 | 0.320 |
Why?
| | Transcription, Genetic | 8 | 2015 | 378 | 0.320 |
Why?
| | Proteomics | 4 | 2025 | 329 | 0.320 |
Why?
| | DNA-Binding Proteins | 5 | 2021 | 422 | 0.310 |
Why?
| | Fibroblasts | 21 | 2001 | 355 | 0.310 |
Why?
| | Transcriptome | 2 | 2019 | 370 | 0.310 |
Why?
| | Protein Binding | 5 | 2018 | 667 | 0.310 |
Why?
| | Somatomedins | 1 | 2018 | 30 | 0.300 |
Why?
| | Simian virus 40 | 6 | 2002 | 14 | 0.300 |
Why?
| | Hot Temperature | 4 | 2013 | 214 | 0.290 |
Why?
| | Proteasome Endopeptidase Complex | 2 | 2018 | 117 | 0.290 |
Why?
| | Lasers | 2 | 2021 | 108 | 0.290 |
Why?
| | Codon, Nonsense | 3 | 2016 | 28 | 0.290 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2018 | 134 | 0.290 |
Why?
| | Membrane Proteins | 2 | 2018 | 335 | 0.280 |
Why?
| | Nucleotide Motifs | 1 | 2017 | 23 | 0.280 |
Why?
| | Replication Origin | 1 | 2017 | 11 | 0.280 |
Why?
| | RNA, Transfer | 1 | 2017 | 13 | 0.280 |
Why?
| | Insulin | 2 | 2018 | 479 | 0.280 |
Why?
| | Models, Genetic | 2 | 2015 | 169 | 0.270 |
Why?
| | Computational Biology | 1 | 2018 | 212 | 0.260 |
Why?
| | Phosphatidylinositol 4,5-Diphosphate | 1 | 2016 | 11 | 0.260 |
Why?
| | Muscles | 1 | 2016 | 107 | 0.260 |
Why?
| | Antigens, Polyomavirus Transforming | 4 | 2002 | 9 | 0.260 |
Why?
| | Caloric Restriction | 2 | 2015 | 38 | 0.250 |
Why?
| | Molecular Docking Simulation | 3 | 2023 | 88 | 0.250 |
Why?
| | Telomere | 4 | 2004 | 38 | 0.250 |
Why?
| | Pyridinium Compounds | 1 | 2015 | 20 | 0.250 |
Why?
| | Aldehydes | 2 | 2006 | 81 | 0.250 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2015 | 26 | 0.250 |
Why?
| | Homologous Recombination | 1 | 2015 | 41 | 0.250 |
Why?
| | Polymerase Chain Reaction | 8 | 2008 | 461 | 0.240 |
Why?
| | Benzimidazoles | 1 | 2015 | 49 | 0.240 |
Why?
| | Proprotein Convertases | 1 | 2015 | 8 | 0.240 |
Why?
| | Gene Expression Profiling | 4 | 2015 | 1105 | 0.240 |
Why?
| | Serine Endopeptidases | 1 | 2015 | 50 | 0.230 |
Why?
| | Repetitive Sequences, Nucleic Acid | 9 | 2000 | 90 | 0.230 |
Why?
| | DNA Transposable Elements | 6 | 2005 | 107 | 0.230 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2015 | 93 | 0.230 |
Why?
| | Protein Conformation | 3 | 2020 | 176 | 0.230 |
Why?
| | Lipids | 2 | 2016 | 155 | 0.230 |
Why?
| | Microscopy, Fluorescence | 2 | 2012 | 160 | 0.230 |
Why?
| | Bone Density | 4 | 2006 | 399 | 0.220 |
Why?
| | Melphalan | 1 | 2015 | 181 | 0.220 |
Why?
| | Cryoprotective Agents | 1 | 2024 | 6 | 0.220 |
Why?
| | Proteasome Inhibitors | 1 | 2014 | 104 | 0.220 |
Why?
| | Cell Transformation, Neoplastic | 5 | 2001 | 184 | 0.220 |
Why?
| | Cell Line | 10 | 2018 | 1030 | 0.220 |
Why?
| | Cryopreservation | 1 | 2024 | 41 | 0.210 |
Why?
| | Models, Molecular | 3 | 2020 | 348 | 0.210 |
Why?
| | Cell Division | 13 | 2004 | 291 | 0.210 |
Why?
| | Cell Survival | 10 | 2015 | 612 | 0.210 |
Why?
| | Mosquito Control | 1 | 2013 | 6 | 0.210 |
Why?
| | Aedes | 1 | 2013 | 12 | 0.210 |
Why?
| | Scavenger Receptors, Class E | 1 | 2015 | 204 | 0.200 |
Why?
| | Drug Resistance, Neoplasm | 1 | 2015 | 326 | 0.200 |
Why?
| | Gametogenesis | 1 | 2012 | 2 | 0.200 |
Why?
| | Quantitative Trait, Heritable | 3 | 2001 | 16 | 0.200 |
Why?
| | Computer Simulation | 3 | 2018 | 290 | 0.190 |
Why?
| | Photoacoustic Techniques | 1 | 2013 | 71 | 0.190 |
Why?
| | Cell Transformation, Viral | 4 | 2002 | 25 | 0.190 |
Why?
| | Metal Nanoparticles | 1 | 2013 | 86 | 0.190 |
Why?
| | Gold | 1 | 2013 | 128 | 0.190 |
Why?
| | Cell Line, Tumor | 6 | 2015 | 1470 | 0.190 |
Why?
| | Microscopy, Confocal | 1 | 2012 | 86 | 0.190 |
Why?
| | Binding Sites | 3 | 2020 | 377 | 0.190 |
Why?
| | Gene Knockdown Techniques | 3 | 2016 | 108 | 0.190 |
Why?
| | Cells, Cultured | 16 | 2016 | 1567 | 0.190 |
Why?
| | Signal Transduction | 4 | 2018 | 1671 | 0.180 |
Why?
| | Down-Regulation | 2 | 2011 | 346 | 0.180 |
Why?
| | Fluorescent Dyes | 1 | 2012 | 105 | 0.180 |
Why?
| | Data Mining | 1 | 2011 | 44 | 0.180 |
Why?
| | Hypoxanthine Phosphoribosyltransferase | 4 | 2001 | 21 | 0.180 |
Why?
| | Alu Elements | 1 | 2011 | 7 | 0.180 |
Why?
| | Gene Expression Regulation | 4 | 2009 | 990 | 0.180 |
Why?
| | Cell Line, Transformed | 7 | 2017 | 74 | 0.180 |
Why?
| | Barrett Esophagus | 1 | 2011 | 31 | 0.180 |
Why?
| | Dependovirus | 2 | 2002 | 103 | 0.170 |
Why?
| | Animals, Genetically Modified | 4 | 2018 | 52 | 0.170 |
Why?
| | Plasmids | 8 | 2005 | 163 | 0.170 |
Why?
| | Genome, Human | 1 | 2011 | 121 | 0.170 |
Why?
| | Esophageal Neoplasms | 2 | 2011 | 111 | 0.170 |
Why?
| | Werner Syndrome | 4 | 1991 | 14 | 0.170 |
Why?
| | Dose-Response Relationship, Drug | 4 | 2021 | 1378 | 0.170 |
Why?
| | Obesity | 1 | 2018 | 1162 | 0.170 |
Why?
| | Histoplasma | 1 | 2009 | 24 | 0.160 |
Why?
| | Genetic Markers | 5 | 2003 | 109 | 0.160 |
Why?
| | Enzyme Inhibitors | 2 | 2003 | 372 | 0.160 |
Why?
| | Multigene Family | 3 | 1997 | 48 | 0.160 |
Why?
| | Histoplasmosis | 1 | 2009 | 47 | 0.160 |
Why?
| | Lipid Peroxidation | 2 | 2007 | 97 | 0.160 |
Why?
| | Peptides | 2 | 2021 | 223 | 0.150 |
Why?
| | Bone and Bones | 1 | 2003 | 494 | 0.150 |
Why?
| | Amino Acid Sequence | 2 | 2021 | 578 | 0.150 |
Why?
| | Biopolymers | 1 | 2008 | 15 | 0.150 |
Why?
| | Catalytic Domain | 2 | 2020 | 60 | 0.150 |
Why?
| | Pattern Recognition, Automated | 1 | 2008 | 40 | 0.150 |
Why?
| | Sequence Alignment | 1 | 2008 | 125 | 0.150 |
Why?
| | Spine | 2 | 2006 | 89 | 0.150 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2008 | 69 | 0.150 |
Why?
| | Antineoplastic Agents | 2 | 2015 | 1222 | 0.150 |
Why?
| | RNA, Messenger | 9 | 2017 | 1132 | 0.150 |
Why?
| | Bone Diseases, Metabolic | 2 | 2000 | 78 | 0.150 |
Why?
| | Adenocarcinoma | 2 | 2011 | 405 | 0.140 |
Why?
| | Oligonucleotide Array Sequence Analysis | 3 | 2009 | 405 | 0.140 |
Why?
| | DNA, Circular | 6 | 1990 | 18 | 0.140 |
Why?
| | Genotype | 5 | 2017 | 566 | 0.140 |
Why?
| | X Chromosome | 1 | 2006 | 13 | 0.130 |
Why?
| | Models, Animal | 3 | 2019 | 234 | 0.130 |
Why?
| | Male | 15 | 2025 | 26761 | 0.130 |
Why?
| | Ubiquitin | 2 | 2018 | 47 | 0.130 |
Why?
| | Artificial Intelligence | 1 | 2008 | 115 | 0.130 |
Why?
| | Apoptosis | 3 | 2004 | 1119 | 0.130 |
Why?
| | Molecular Dynamics Simulation | 2 | 2017 | 44 | 0.130 |
Why?
| | Receptor, Insulin | 1 | 2005 | 37 | 0.120 |
Why?
| | Heat-Shock Proteins | 2 | 2023 | 103 | 0.120 |
Why?
| | Growth Inhibitors | 1 | 2005 | 26 | 0.120 |
Why?
| | Selection, Genetic | 1 | 2005 | 28 | 0.120 |
Why?
| | Chorionic Gonadotropin | 4 | 1990 | 19 | 0.120 |
Why?
| | Phosphorylation | 2 | 2017 | 528 | 0.120 |
Why?
| | Genes, Helminth | 2 | 2006 | 5 | 0.120 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 23 | 0.120 |
Why?
| | Point Mutation | 1 | 2005 | 67 | 0.120 |
Why?
| | Recombinant Fusion Proteins | 2 | 2021 | 177 | 0.120 |
Why?
| | Cell Death | 2 | 2016 | 177 | 0.120 |
Why?
| | Xenograft Model Antitumor Assays | 2 | 2015 | 220 | 0.120 |
Why?
| | Up-Regulation | 2 | 2011 | 454 | 0.120 |
Why?
| | Algorithms | 1 | 2008 | 672 | 0.110 |
Why?
| | Genes, Viral | 2 | 2002 | 39 | 0.110 |
Why?
| | Hydrogen Peroxide | 3 | 2016 | 120 | 0.110 |
Why?
| | Genetic Predisposition to Disease | 2 | 2006 | 528 | 0.110 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2015 | 857 | 0.110 |
Why?
| | Oxazoles | 1 | 2004 | 9 | 0.110 |
Why?
| | Activating Transcription Factor 6 | 1 | 2023 | 16 | 0.110 |
Why?
| | Porphyrins | 1 | 2003 | 10 | 0.110 |
Why?
| | Models, Biological | 7 | 2009 | 735 | 0.110 |
Why?
| | Reactive Oxygen Species | 3 | 2015 | 421 | 0.110 |
Why?
| | Viral Proteins | 2 | 2002 | 164 | 0.100 |
Why?
| | Guanosine Triphosphate | 1 | 2023 | 17 | 0.100 |
Why?
| | Cloning, Molecular | 8 | 2000 | 190 | 0.100 |
Why?
| | Transfection | 5 | 2008 | 357 | 0.100 |
Why?
| | Tubulin | 1 | 2023 | 21 | 0.100 |
Why?
| | Genes | 5 | 1996 | 31 | 0.100 |
Why?
| | Microtubules | 1 | 2023 | 39 | 0.100 |
Why?
| | Exosomes | 1 | 2023 | 58 | 0.100 |
Why?
| | Forkhead Transcription Factors | 3 | 2009 | 116 | 0.100 |
Why?
| | Time Factors | 5 | 2019 | 2968 | 0.100 |
Why?
| | Life Expectancy | 2 | 2012 | 34 | 0.100 |
Why?
| | Saccharomyces cerevisiae | 2 | 2024 | 176 | 0.100 |
Why?
| | Hematopoiesis | 1 | 2022 | 69 | 0.090 |
Why?
| | Osteoporosis | 1 | 2003 | 162 | 0.090 |
Why?
| | Gene Deletion | 2 | 2006 | 272 | 0.090 |
Why?
| | Drosophila melanogaster | 2 | 2015 | 32 | 0.090 |
Why?
| | Geriatrics | 1 | 2012 | 47 | 0.090 |
Why?
| | Electrophorus | 1 | 2021 | 5 | 0.090 |
Why?
| | Butyrylcholinesterase | 1 | 2021 | 8 | 0.090 |
Why?
| | Epistasis, Genetic | 2 | 2017 | 31 | 0.090 |
Why?
| | Mice, Inbred C57BL | 3 | 2023 | 1884 | 0.090 |
Why?
| | Acetylcholinesterase | 1 | 2021 | 20 | 0.090 |
Why?
| | Coronary Artery Disease | 1 | 2005 | 294 | 0.090 |
Why?
| | Horses | 1 | 2021 | 49 | 0.090 |
Why?
| | Protein Folding | 1 | 2021 | 50 | 0.090 |
Why?
| | Actins | 3 | 2018 | 115 | 0.090 |
Why?
| | Myocardium | 1 | 2023 | 453 | 0.090 |
Why?
| | Taq Polymerase | 1 | 2000 | 4 | 0.090 |
Why?
| | Base Pair Mismatch | 1 | 2000 | 21 | 0.090 |
Why?
| | Ataxia Telangiectasia | 2 | 1999 | 6 | 0.090 |
Why?
| | Disease Progression | 2 | 2017 | 871 | 0.090 |
Why?
| | Hypertension | 1 | 2016 | 565 | 0.090 |
Why?
| | Chemistry Techniques, Synthetic | 1 | 2020 | 21 | 0.090 |
Why?
| | Food Deprivation | 1 | 2000 | 30 | 0.090 |
Why?
| | RNA, Viral | 1 | 2021 | 127 | 0.090 |
Why?
| | Molecular Structure | 1 | 2021 | 314 | 0.090 |
Why?
| | Fungi | 2 | 1997 | 51 | 0.090 |
Why?
| | Cell Cycle | 4 | 2004 | 230 | 0.090 |
Why?
| | Protein Structure, Secondary | 1 | 2020 | 71 | 0.090 |
Why?
| | Drosophila | 2 | 1997 | 17 | 0.080 |
Why?
| | Hematopoietic Stem Cells | 1 | 2022 | 187 | 0.080 |
Why?
| | Glioma | 1 | 2021 | 78 | 0.080 |
Why?
| | Structure-Activity Relationship | 1 | 2021 | 404 | 0.080 |
Why?
| | RNA-Binding Proteins | 1 | 2021 | 128 | 0.080 |
Why?
| | Aged | 8 | 2025 | 10121 | 0.080 |
Why?
| | Loss of Heterozygosity | 2 | 2011 | 78 | 0.080 |
Why?
| | HEK293 Cells | 1 | 2020 | 229 | 0.080 |
Why?
| | Transcription Factors | 3 | 2009 | 566 | 0.080 |
Why?
| | Trans-Activators | 1 | 2001 | 135 | 0.080 |
Why?
| | Proteome | 1 | 2021 | 171 | 0.080 |
Why?
| | Dipyrone | 1 | 2019 | 2 | 0.080 |
Why?
| | Anisomycin | 1 | 2019 | 3 | 0.080 |
Why?
| | Camptothecin | 1 | 2019 | 15 | 0.080 |
Why?
| | Species Specificity | 3 | 2006 | 192 | 0.080 |
Why?
| | Benzazepines | 1 | 2019 | 20 | 0.080 |
Why?
| | Survival Rate | 2 | 2013 | 945 | 0.080 |
Why?
| | Azacitidine | 1 | 2019 | 39 | 0.080 |
Why?
| | Gene Expression | 5 | 2006 | 618 | 0.080 |
Why?
| | DNA Damage | 3 | 2015 | 305 | 0.080 |
Why?
| | DNA Helicases | 1 | 2001 | 150 | 0.080 |
Why?
| | Protein Unfolding | 1 | 2018 | 7 | 0.080 |
Why?
| | Hydrogen Bonding | 1 | 2018 | 35 | 0.080 |
Why?
| | Age Factors | 5 | 2016 | 1132 | 0.080 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2018 | 36 | 0.080 |
Why?
| | Mutant Proteins | 1 | 2018 | 37 | 0.070 |
Why?
| | Base Sequence | 7 | 1997 | 640 | 0.070 |
Why?
| | Female | 10 | 2025 | 28171 | 0.070 |
Why?
| | DNA Nucleotidyltransferases | 1 | 1997 | 2 | 0.070 |
Why?
| | Aging, Premature | 1 | 1997 | 5 | 0.070 |
Why?
| | Mutagenicity Tests | 1 | 1997 | 41 | 0.070 |
Why?
| | Integrases | 1 | 1997 | 44 | 0.070 |
Why?
| | Apolipoprotein E3 | 1 | 2017 | 9 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 483 | 0.070 |
Why?
| | Halothane | 1 | 1997 | 3 | 0.070 |
Why?
| | Mice, Knockout | 2 | 2015 | 879 | 0.070 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2017 | 20 | 0.070 |
Why?
| | Electrophoretic Mobility Shift Assay | 1 | 2017 | 74 | 0.070 |
Why?
| | Nematoda | 1 | 1997 | 2 | 0.070 |
Why?
| | Mammals | 3 | 2006 | 61 | 0.070 |
Why?
| | Anesthetics, Inhalation | 1 | 1997 | 32 | 0.070 |
Why?
| | Acetylation | 1 | 2017 | 95 | 0.070 |
Why?
| | Mice, Transgenic | 1 | 2018 | 552 | 0.070 |
Why?
| | Carrier Proteins | 1 | 2018 | 313 | 0.070 |
Why?
| | Absorptiometry, Photon | 3 | 2006 | 162 | 0.070 |
Why?
| | Intermediate Filament Proteins | 1 | 2016 | 12 | 0.070 |
Why?
| | Detergents | 1 | 2016 | 15 | 0.070 |
Why?
| | Carcinogens | 1 | 1997 | 193 | 0.070 |
Why?
| | Thermodynamics | 1 | 2016 | 35 | 0.070 |
Why?
| | tau Proteins | 1 | 2016 | 27 | 0.060 |
Why?
| | Solubility | 1 | 2016 | 79 | 0.060 |
Why?
| | Indolizines | 1 | 2015 | 5 | 0.060 |
Why?
| | Cyclic N-Oxides | 1 | 2015 | 12 | 0.060 |
Why?
| | Skin | 3 | 1991 | 422 | 0.060 |
Why?
| | Ligands | 1 | 2016 | 206 | 0.060 |
Why?
| | Synteny | 1 | 2005 | 7 | 0.060 |
Why?
| | Mole Rats | 1 | 2015 | 1 | 0.060 |
Why?
| | Polymorphism, Single Nucleotide | 3 | 2006 | 505 | 0.060 |
Why?
| | Chromosomes, Human, X | 1 | 2005 | 18 | 0.060 |
Why?
| | Principal Component Analysis | 1 | 2015 | 53 | 0.060 |
Why?
| | Drug Synergism | 1 | 2015 | 150 | 0.060 |
Why?
| | Mice, SCID | 1 | 2015 | 182 | 0.060 |
Why?
| | S Phase | 1 | 2015 | 19 | 0.060 |
Why?
| | Diploidy | 4 | 1997 | 25 | 0.060 |
Why?
| | Genes, BRCA1 | 1 | 2015 | 19 | 0.060 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2015 | 39 | 0.060 |
Why?
| | Neoplasms | 1 | 2005 | 1325 | 0.060 |
Why?
| | Crosses, Genetic | 3 | 2005 | 34 | 0.060 |
Why?
| | Alleles | 2 | 2009 | 276 | 0.060 |
Why?
| | Promoter Regions, Genetic | 2 | 2008 | 467 | 0.060 |
Why?
| | Fluorescent Antibody Technique | 1 | 2014 | 111 | 0.060 |
Why?
| | Fertility | 1 | 2014 | 32 | 0.060 |
Why?
| | Protein Multimerization | 1 | 2014 | 56 | 0.060 |
Why?
| | Cytokines | 1 | 2017 | 623 | 0.060 |
Why?
| | Vitrification | 1 | 2024 | 4 | 0.060 |
Why?
| | Hormesis | 1 | 2024 | 10 | 0.060 |
Why?
| | Phylogeny | 1 | 1995 | 231 | 0.060 |
Why?
| | Phenotype | 2 | 2003 | 789 | 0.050 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2007 | 137 | 0.050 |
Why?
| | Methylation | 7 | 1990 | 126 | 0.050 |
Why?
| | Lipopolysaccharides | 1 | 2015 | 206 | 0.050 |
Why?
| | Sequence Deletion | 1 | 1994 | 73 | 0.050 |
Why?
| | Lipoproteins, LDL | 1 | 2015 | 169 | 0.050 |
Why?
| | NF-kappa B | 1 | 2015 | 322 | 0.050 |
Why?
| | Blotting, Western | 1 | 2014 | 590 | 0.050 |
Why?
| | Endothelial Cells | 1 | 2015 | 262 | 0.050 |
Why?
| | Mice, Congenic | 1 | 2003 | 6 | 0.050 |
Why?
| | Genetic Techniques | 1 | 2003 | 15 | 0.050 |
Why?
| | Case-Control Studies | 1 | 2016 | 1201 | 0.050 |
Why?
| | DNA Restriction Enzymes | 6 | 1990 | 19 | 0.050 |
Why?
| | Dose-Response Relationship, Radiation | 1 | 2013 | 184 | 0.050 |
Why?
| | Genes, Essential | 1 | 2012 | 11 | 0.050 |
Why?
| | Young Adult | 2 | 2016 | 4329 | 0.050 |
Why?
| | Systems Biology | 1 | 2012 | 33 | 0.050 |
Why?
| | Locomotion | 1 | 2012 | 85 | 0.050 |
Why?
| | Intracellular Space | 1 | 2012 | 26 | 0.050 |
Why?
| | Databases, Genetic | 1 | 2012 | 83 | 0.050 |
Why?
| | Radiation Dosage | 1 | 2013 | 163 | 0.050 |
Why?
| | Melanins | 1 | 2012 | 28 | 0.050 |
Why?
| | Biological Evolution | 1 | 2012 | 52 | 0.050 |
Why?
| | Ribosomes | 1 | 1981 | 33 | 0.050 |
Why?
| | Gene Amplification | 3 | 1985 | 58 | 0.050 |
Why?
| | Glycoside Hydrolases | 1 | 1991 | 18 | 0.050 |
Why?
| | Clone Cells | 3 | 1997 | 77 | 0.050 |
Why?
| | Gene Expression Regulation, Viral | 2 | 2002 | 49 | 0.050 |
Why?
| | Oxidants | 1 | 2011 | 51 | 0.040 |
Why?
| | Poly A | 1 | 1990 | 10 | 0.040 |
Why?
| | Imaging, Three-Dimensional | 1 | 2012 | 154 | 0.040 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 1 | 1990 | 3 | 0.040 |
Why?
| | Fatty Acids | 1 | 2011 | 149 | 0.040 |
Why?
| | RNA-Directed DNA Polymerase | 1 | 1990 | 5 | 0.040 |
Why?
| | Genes, ras | 1 | 1990 | 43 | 0.040 |
Why?
| | Cytosine | 2 | 1990 | 30 | 0.040 |
Why?
| | Reference Values | 2 | 2016 | 313 | 0.040 |
Why?
| | Adult | 6 | 2016 | 14161 | 0.040 |
Why?
| | Microscopy | 1 | 2009 | 60 | 0.040 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 1031 | 0.040 |
Why?
| | Aphidicolin | 2 | 2001 | 2 | 0.040 |
Why?
| | Protein Biosynthesis | 1 | 1981 | 258 | 0.040 |
Why?
| | Nucleic Acid Hybridization | 5 | 1985 | 56 | 0.040 |
Why?
| | Proto-Oncogene Proteins | 1 | 1990 | 151 | 0.040 |
Why?
| | Kidney | 1 | 2024 | 707 | 0.040 |
Why?
| | Virulence | 1 | 2009 | 167 | 0.040 |
Why?
| | Hydroxyurea | 2 | 2001 | 30 | 0.040 |
Why?
| | Aged, 80 and over | 1 | 2016 | 3392 | 0.040 |
Why?
| | DNA Primers | 2 | 2000 | 208 | 0.040 |
Why?
| | Evolution, Molecular | 1 | 2009 | 93 | 0.040 |
Why?
| | Host-Pathogen Interactions | 1 | 2009 | 144 | 0.040 |
Why?
| | RNA, Small Interfering | 1 | 2008 | 213 | 0.040 |
Why?
| | Diet | 1 | 2012 | 587 | 0.040 |
Why?
| | Oogenesis | 1 | 2007 | 18 | 0.040 |
Why?
| | Lesch-Nyhan Syndrome | 2 | 1997 | 2 | 0.040 |
Why?
| | Electroporation | 2 | 2004 | 18 | 0.030 |
Why?
| | Histones | 1 | 1989 | 314 | 0.030 |
Why?
| | Gene Library | 2 | 2000 | 44 | 0.030 |
Why?
| | Genes, Insect | 1 | 2006 | 11 | 0.030 |
Why?
| | Antigens, Viral, Tumor | 2 | 2001 | 6 | 0.030 |
Why?
| | Mutagens | 1 | 2006 | 51 | 0.030 |
Why?
| | Middle Aged | 4 | 2016 | 13028 | 0.030 |
Why?
| | Mutagenesis | 1 | 2006 | 61 | 0.030 |
Why?
| | Environment | 1 | 2006 | 89 | 0.030 |
Why?
| | Tissue Distribution | 1 | 2016 | 171 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2008 | 979 | 0.030 |
Why?
| | Myofibroblasts | 1 | 2016 | 50 | 0.030 |
Why?
| | Liver | 1 | 1981 | 1156 | 0.030 |
Why?
| | Regression Analysis | 1 | 2006 | 401 | 0.030 |
Why?
| | Electrophoresis | 1 | 2005 | 16 | 0.030 |
Why?
| | Rats | 2 | 2005 | 3220 | 0.030 |
Why?
| | Isoenzymes | 1 | 2005 | 166 | 0.030 |
Why?
| | Oncogenes | 1 | 1985 | 60 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2006 | 591 | 0.030 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2005 | 139 | 0.030 |
Why?
| | Rats, Inbred F344 | 1 | 2005 | 197 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 2005 | 180 | 0.030 |
Why?
| | Ultraviolet Rays | 2 | 1997 | 50 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2006 | 273 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2005 | 179 | 0.030 |
Why?
| | Oligonucleotide Probes | 2 | 1996 | 19 | 0.030 |
Why?
| | Sex Factors | 1 | 2006 | 727 | 0.030 |
Why?
| | Cerebral Cortex | 1 | 2005 | 198 | 0.030 |
Why?
| | Deoxyribonuclease I | 1 | 2003 | 33 | 0.030 |
Why?
| | Animals, Congenic | 1 | 2003 | 3 | 0.030 |
Why?
| | Animals, Inbred Strains | 1 | 2003 | 5 | 0.030 |
Why?
| | Tumor Cells, Cultured | 1 | 2003 | 460 | 0.020 |
Why?
| | DNA Repair | 1 | 2004 | 195 | 0.020 |
Why?
| | G-Quadruplexes | 1 | 2003 | 77 | 0.020 |
Why?
| | Internationality | 1 | 2012 | 43 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 1995 | 778 | 0.020 |
Why?
| | Nucleic Acid Denaturation | 2 | 1985 | 13 | 0.020 |
Why?
| | Kinetics | 3 | 1991 | 626 | 0.020 |
Why?
| | DNA, Viral | 1 | 2002 | 137 | 0.020 |
Why?
| | Helper Viruses | 1 | 2001 | 6 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2001 | 63 | 0.020 |
Why?
| | Homozygote | 1 | 2001 | 59 | 0.020 |
Why?
| | Heterozygote | 1 | 2001 | 90 | 0.020 |
Why?
| | Templates, Genetic | 1 | 2000 | 13 | 0.020 |
Why?
| | Chromosomes, Artificial, Yeast | 1 | 2000 | 7 | 0.020 |
Why?
| | Sequence Homology | 1 | 2000 | 16 | 0.020 |
Why?
| | Larva | 1 | 2000 | 32 | 0.020 |
Why?
| | Mice, Inbred AKR | 1 | 2000 | 6 | 0.020 |
Why?
| | Blotting, Northern | 2 | 1991 | 106 | 0.020 |
Why?
| | DNA, Complementary | 1 | 2000 | 135 | 0.020 |
Why?
| | Polymorphism, Genetic | 1 | 2001 | 185 | 0.020 |
Why?
| | Data Interpretation, Statistical | 1 | 2001 | 164 | 0.020 |
Why?
| | Amino Acid Metabolism, Inborn Errors | 1 | 1999 | 14 | 0.020 |
Why?
| | Enzyme Induction | 1 | 1999 | 77 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2005 | 804 | 0.020 |
Why?
| | Invertebrates | 1 | 1989 | 4 | 0.020 |
Why?
| | Molecular Probes | 1 | 1988 | 8 | 0.020 |
Why?
| | Aminopterin | 1 | 1997 | 2 | 0.020 |
Why?
| | Sensitivity and Specificity | 1 | 2000 | 891 | 0.020 |
Why?
| | Recombinases | 1 | 1997 | 10 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 1997 | 66 | 0.020 |
Why?
| | Viral Structural Proteins | 1 | 1997 | 6 | 0.020 |
Why?
| | Hypoxanthine | 1 | 1997 | 5 | 0.020 |
Why?
| | Thymidine | 1 | 1997 | 17 | 0.020 |
Why?
| | Transformation, Genetic | 1 | 1997 | 17 | 0.020 |
Why?
| | Sexual Behavior, Animal | 1 | 1997 | 6 | 0.020 |
Why?
| | Culture Media | 1 | 1997 | 98 | 0.020 |
Why?
| | Drug Resistance | 1 | 1997 | 65 | 0.020 |
Why?
| | Methotrexate | 1 | 1997 | 77 | 0.020 |
Why?
| | Centrifugation, Density Gradient | 1 | 1985 | 17 | 0.020 |
Why?
| | DNA, Recombinant | 1 | 1985 | 15 | 0.020 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 1985 | 6 | 0.020 |
Why?
| | Research Design | 1 | 1988 | 359 | 0.020 |
Why?
| | DNA, Helminth | 1 | 1995 | 2 | 0.020 |
Why?
| | Haplotypes | 1 | 2005 | 92 | 0.010 |
Why?
| | Glucocorticoids | 1 | 1997 | 235 | 0.010 |
Why?
| | Femur | 1 | 2005 | 135 | 0.010 |
Why?
| | Dexamethasone | 1 | 1997 | 438 | 0.010 |
Why?
| | Linear Models | 1 | 2005 | 287 | 0.010 |
Why?
| | Lumbar Vertebrae | 1 | 2005 | 104 | 0.010 |
Why?
| | Child | 4 | 1985 | 7248 | 0.010 |
Why?
| | Escherichia coli | 1 | 1985 | 192 | 0.010 |
Why?
| | Base Composition | 2 | 1985 | 23 | 0.010 |
Why?
| | Blotting, Southern | 1 | 1994 | 42 | 0.010 |
Why?
| | Extrachromosomal Inheritance | 1 | 1983 | 3 | 0.010 |
Why?
| | Globins | 2 | 1982 | 14 | 0.010 |
Why?
| | Polyribosomes | 1 | 1981 | 7 | 0.010 |
Why?
| | Poly U | 1 | 1981 | 5 | 0.010 |
Why?
| | Cell-Free System | 1 | 1981 | 12 | 0.010 |
Why?
| | Mice, Inbred CBA | 1 | 1981 | 37 | 0.010 |
Why?
| | alpha-Mannosidase | 1 | 1991 | 3 | 0.010 |
Why?
| | beta-N-Acetylhexosaminidases | 1 | 1991 | 4 | 0.010 |
Why?
| | Mannosidases | 1 | 1991 | 5 | 0.010 |
Why?
| | beta-Galactosidase | 1 | 1991 | 33 | 0.010 |
Why?
| | Glucuronidase | 1 | 1991 | 47 | 0.010 |
Why?
| | Nucleotide Mapping | 1 | 1990 | 2 | 0.010 |
Why?
| | Chorionic Gonadotropin, beta Subunit, Human | 1 | 1990 | 4 | 0.010 |
Why?
| | Nucleotides | 1 | 1990 | 24 | 0.010 |
Why?
| | Electrophoresis, Agar Gel | 1 | 1990 | 12 | 0.010 |
Why?
| | Genes, Regulator | 1 | 1990 | 5 | 0.010 |
Why?
| | Restriction Mapping | 1 | 1990 | 33 | 0.010 |
Why?
| | DNA Probes | 1 | 1990 | 28 | 0.010 |
Why?
| | Contact Inhibition | 1 | 1989 | 3 | 0.010 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 1990 | 69 | 0.010 |
Why?
| | Gene Rearrangement | 1 | 1989 | 75 | 0.010 |
Why?
| | Genetic Variation | 1 | 1990 | 230 | 0.010 |
Why?
| | Glycoproteins | 1 | 1989 | 122 | 0.010 |
Why?
| | Breeding | 1 | 1996 | 7 | 0.010 |
Why?
| | 5-Methylcytosine | 1 | 1985 | 16 | 0.010 |
Why?
| | Catalase | 1 | 1996 | 73 | 0.010 |
Why?
| | Superoxide Dismutase | 1 | 1996 | 119 | 0.010 |
Why?
| | Temperature | 1 | 1985 | 183 | 0.010 |
Why?
| | Analysis of Variance | 1 | 1996 | 554 | 0.010 |
Why?
| | Lymphocytes | 2 | 1985 | 153 | 0.010 |
Why?
| | Proto-Oncogenes | 1 | 1985 | 27 | 0.000 |
Why?
| | Chromosomes, Human | 1 | 1985 | 41 | 0.000 |
Why?
|
|
Reis's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|